Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board
Zoetis, an animal health company spun off from Pfizer in 2013, is taking a representative from Bill Ackman's hedge fund Pershing Square Capital Management onto its board of directors...
Related Articles
- Comcast Boosts Stock Buyback Nearly 60% After Time Warner Cable Deal Bust also written by Antoine Gara
- Ackman Expects 'Influence' in Air Products CEO Search also written by Antoine Gara
- Benjamin McLean appointed to UFPI Board of Directors also categorized in BoardMoves
- Dixie Brands Announces Changes to Board of Directors also categorized in BoardMoves
- Cool Technologies Elects New Board Member also categorized in BoardMoves
- DuPont's Activist Response Has Perfect Formula To Counter Trian's Nelson Peltz also written by Antoine Gara
- Getting Gen-Y on Boards (of Directors) also published in forbes.com
- Warren Buffett And CalSTRS Agree On Brian Moynihan's Performance At Bank Of America also written by Antoine Gara
- Verisk Elects Laura K. Ipsen to Board of Directors also categorized in BoardMoves
- Six Years Later, The Problem at HP is Still the Board also published in forbes.com
Login to comment.